A carregar...
Current approaches to selection of the 1st line therapy in patients with metastatic hormone-sensitive prostate cancer
Hormone therapy of metastatic prostate cancer (mPC) has been the “golden standard” of treatment since 1941. However, survival rates in patients with this pathology have remained low. Based on the results of newer studies, early start of docetaxel chemotherapy or antiandrogen abiraterone therapy in c...
Na minha lista:
| Main Authors: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Russo |
| Publicado em: |
ABV-press
2017-12-01
|
| Colecção: | Onkourologiâ |
| Assuntos: | |
| Acesso em linha: | https://oncourology.abvpress.ru/oncur/article/view/770 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|